Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Perrigo
(NY:
PRGO
)
13.31
-0.05 (-0.37%)
Official Closing Price
Updated: 7:00 PM EST, Dec 18, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Perrigo
< Previous
1
2
3
4
5
6
Next >
A Peek at Perrigo's Future Earnings
↗
August 05, 2025
Via
Benzinga
These 3 Dividend Stocks Combine Strong Yields With Upside
June 20, 2025
These three high-yield dividend stocks are well-positioned to deliver a strong return, making them attractive to both income and growth-oriented investors
Via
MarketBeat
Topics
World Trade
Earnings Scheduled For May 7, 2025
↗
May 07, 2025
Via
Benzinga
Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan
↗
April 21, 2025
JP Morgan warns tariffs could impact Perrigo's near-term earnings, though efficiencies and price hikes may ease pressure by 2026.
Via
Benzinga
Topics
Government
World Trade
Nasdaq, S&P 500 Head for Worst Weekly Losses Since September
↗
February 28, 2025
Stocks are higher midday, getting a much-needed lift from this morning's inflation data that came in line with estimates.
Via
Talk Markets
Topics
Economy
Stocks
Stocks / Equities
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2024
↗
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Perrigo Supports Customers through Tough Times, Supporting Shareholders through Changes
↗
December 19, 2023
Via
Benzinga
Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027
↗
February 28, 2025
Perrigo Company shares surged after issuing financial targets for 2025 & 2025-2027 on investor day. Expect sales growth, EPS, and margin expansion. 'Three-S' plan will enhance cash flow & shareholder...
Via
Benzinga
These stocks are gapping in today's session
↗
February 28, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Via
Chartmill
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
↗
December 22, 2024
JP Morgan highlights 2025 growth prospects for biopharma, animal health, and specialty pharma stocks. Key picks include Eli Lilly, Zoetis, and Bristol-Myers Squibb.
Via
Benzinga
JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability
↗
September 06, 2024
JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.
Via
Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q2 2024
↗
August 02, 2024
PRGO stock results show that Perrigo beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Abbott Labs (ABT) Stock Falls on Baby Formula Ruling. What to Know.
↗
July 29, 2024
ABT stock is in focus on ruling news. Abbott faced a suit last year over the closing of its Michigan plant resulting in a formula shortage.
Via
InvestorPlace
AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case
↗
July 12, 2024
AbbVie petitions the U.S. Supreme Court to protect its corporate records, arguing a lower court ruling threatens attorney-client privilege.
Via
Benzinga
$20M Bet On This Energy Stock? Check Out These 3 Stocks Insiders Are Buying
↗
June 03, 2024
Via
Benzinga
PRGO Stock Earnings: Perrigo Beats EPS, Misses Revenue for Q1 2024
↗
May 07, 2024
PRGO stock results show that Perrigo beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Disney To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Monday
↗
April 08, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 07, 2024
Via
Benzinga
CVS Health's Zero-Cost Coverage Paves Way For OTC Birth Control Access
↗
April 05, 2024
CVS Health expands coverage to include the first OTC birth control pill in the U.S., offering accessible contraception without prescription costs. Learn about this pivotal shift in reproductive...
Via
Benzinga
Hidden Gems: 3 Market Underdogs to Buy at Rock-Bottom Prices
↗
March 03, 2024
While these underdogs stocks might not be on everyone’s radar, they may offer surprisingly robust upside potential.
Via
InvestorPlace
Around $2M Bet On Tile Shop Holdings? Check Out These 4 Stocks Insiders Are Buying
↗
March 01, 2024
Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
Via
Benzinga
Stocks Mixed As Consumer Confidence Falls
↗
February 27, 2024
Stocks are mixed midday, after the most recent batch of economic data.
Via
Talk Markets
OTC Medicine Player Perrigo Outlines Three-Year Cost Saving Plan, Posts Mixed Q4 Earnings
↗
February 27, 2024
Perrigo Q4 2023 net sales reach $1.2 billion, up 0.1% YoY. Explore Project Energize for long-term growth.
Via
Benzinga
Insiders bet big on these turnaround stocks
December 28, 2023
Insiders are buying Bally's, Delcath Systems and Perrigo while their shares are at historic lows and catalysts are ahead.
Via
MarketBeat
Topics
Economy
Initial Public Offering
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
February 27, 2024
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.
Via
Benzinga
Insiders Buying DENTSPLY SIRONA And 2 Other Stocks
↗
November 28, 2023
Although U.S. stocks closed lower on Monday, there were a few notable insider trades.
Via
Benzinga
$1.8M Bet On This Stock? Check Out These 3 Stocks Insiders Are Buying
↗
November 20, 2023
Although U.S. stocks closed slightly higher on Friday, there were a few notable insider trades.
Via
Benzinga
Personal Care Industry Poised For Growth: Analyst Initiates Coverage On These 3 Stocks
↗
November 17, 2023
Piper Sandler analyst Korinne Wolfmeyer initiated coverage on several personal care stocks, noting that amid the present economic conditions, consumers are becoming more discerning in their spending.
Via
Benzinga
Perrigo Cuts Annual Guidance, This OTC Drug Firm Also Reports Mixed Q3 Earnings
↗
November 07, 2023
Perrigo Company PLC (NYSE: PRGO) reported
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today